Iowa
FTC looking to accelerate inquiry into prescription-drug middlemen, chair says
The Federal Trade Commission is looking to speed up its inquiry into prescription-drug middlemen while also expanding its scrutiny of drug patents, FTC Chair Lina Khan said Tuesday.